Blood flow velocities in both middle cerebral arteries and regional cerebral blood flow in their perfu sion territories were measured simultaneously in 36 healthy subjects. In 20 subjects, the measurements were first performed under basal conditions and then repeated 15-20 min after an intravenous injection of 1 g of acet azolamide. Reproducibility of simultaneous blood flow and velocity measurements was tested by examining 16 subjects on two occasions under basal conditions with an interval of 20 min. Relatively good reproducibility was found for repeated measurements of velocity and blood flow, being best when side-to-side asymmetry was as sessed. The increase in blood flow velocities after acet azolamide was symmetrical (right side, 34.2%; and left side, 35.5%), and the velocity increase was significantly correlated with basal values. The increase in cerebral Abbreviations used: SPECT, single-photon emission comput erized tomography; MCA, middle cerebral artery; OM, Orbito meatal plane; PET, positron emission tomography; rCBF, re gional cerebral blood flow; rCBFmca, estimated perfusion terri tory of the MCA; Ro!, region of interest, SPECT, single-photon emission computerized tomography; TCD, transcranial Doppler ultrasound.
The effect of severe carotid occlusive disease on cerebral perfusion depends on the potential collat eral circulation and the ability of the cerebral arte rioles to dilate if there is a fall in perfusion pressure. When the capacity for compensatory vasodilation is overwhelmed and regional cerebral blood flow (rCBF) begins to fall, extraction of oxygen from the blood increases. This sequence of haemodynamic blood flow was also symmetrical (right side, 29.8%; left side, 30.1 %) but not correlated with basal flow values. No significant relationship was found between velocity in crease and increase in regional cerebral blood flow. This finding is probably not only due to methodological inac curacies but may suggest that acetazolamide has an effect on the diameter of the middle cerebral artery or on the magnitude of this artery's perfusion territory. This study supports the use of acetazolamide for assessing cerebral vasoreactivity following the definition of lower limits for velocity and flow increase and for asymmetry of the re sponse. Key Words: Acetazolamide-Cerebral blood flow-Cerebral vasoreactivity-Reproducibility-Simul taneous assessments-Transcranial Doppler ultrasonog raphy. events is best assessed by positron emission tomog raphy (PET), which, in addition to measuring per fusion and cerebral blood volume, can also measure the oxygen extraction ratio and can therefore iden tify the most compromised regions (Powers, 1991) . However, the greater expense and technical com plexity excludes the PET method for routine clini cal use.
The hemodynamic effect of carotid occlusion and severe stenosis may also be assessed by measuring the vasodilatory reserve capacity in the brain. Two methods are commonly used for this purpose: mea surement of rCBF with dynamic single-photon emission computerized tomography (SPECT) and measurement of blood flow velocities in the basal intracranial arteries using trans cranial Doppler ul trasound (TCD). The measurements are performed before and after the application of a potent vasodila tory stimulus, such as carbon dioxide or acetazol-amide (Brown et al., 1986; Vorstrup et al., 1986; Widder et al., 1986; Russell et al., 1990) . Recent studies have shown an increased risk of ischemic episodes in the hemisphere ipsilateral to an oc cluded or stenotic carotid artery when its distribu tion territory had a reduced cerebrovascular va soreactivity (Kleiser and Widder, 1992; Y onas et ai, 1993) .
The rCBF and TCD methods should theoretically provide similar evaluations since changes in volume flow (Q) in an artery and in its perfusion territory are proportional to changes in the artery's cross sectional average blood flow velocity (V) and lumi nal areal (A) according to the formula Q = V x A (Eq. 1). Volume flow (Q) in the artery's perfusion territory (mllmin) can also be calculated from the formula Q = M x rCBF (Eq. 2), where M is the weight (100 g U) of the perfusion territory and rCBF is flow (ml 100 g -1 min -1. When substituting M x rCBF for Q in Eq. 1 the following relationship is obtained: rCBF = V x AIM. Changes in rCBF are therefore proportional to changes in mean velocity providing that the weight of the perfusion territory and the vessel diameter remain constant (Sorteberg et al., 1989a) .
The first aim of this study was to compare rCBF and blood flow velocities under basal conditions and following acetazolamide administration. The measurements were performed simultaneously since rCBF and blood flow velocities can be influ enced by the study situation itself. The latter may cause changes in several factors such as level of mental activity and carbon dioxide tension (Dahl et al., 1992b) . The second aim was to assess the re producibility of rCBF and TCD measurements since this information is mandatory when assessing the significance of changes in these parameters.
MATERIALS AND METHODS
Thirty-six healthy subjects, 13 males and 23 females, aged 24-64 years (mean, 36 years), took part in the study after giving informed consent. Reproducibility of simul taneous rCBF and velocity measurements was assessed in 16 of the 36 subjects. rCBF was measured using SPECT with xenon-133 in halation Medimatic Inc., Copenhagen, Denmmark) . This method has been described in detail previously (Lassen, 1985; Rootwelt et aI., 1986) . The study lasts for 4.5 min, during which 133Xe is inhaled in the first 90 s. Four tomographic pictures of isotope dis tribution are recorded during gas inhalation and the three subsequent 60-s periods. The sequence of tomographic pictures, together with the time-activity curve recorded with a detector positioned over the lung, is used to cal cuhilte rCBF. The rCBF calculation is based on the bolus distribution principle applied to the sum of the first two tomographic pictures together with later measurement of the washout rate. The algorithm used for this calculation is based on a monoexponential washout for xenon-133, which means that mainly changes in gray matter are ob served and used for the calculation.
U sing high-sensitivity collimators, three slices of brain are studied simultaneously. They are 2 cm thick and rou tinely positioned 2, 6, and 10 cm above the orbitomeatal plane (OM). The resolution in the plane of each slice is 1.7 cm (full width, half-maximum). rCBF was calculated (ml 100 g-I min -I ) from slice 2 (OM + 6 cm) in a standard ized region of interest (ROI) in each hemisphere corre sponding approximately to the estimated perfusion terri tory of the middle cerebral artery (MCA) (rCBF me a) . This was obtained using a software package for automatic cal culation of flow values in ROIs (Rootwelt et aI., 1986) .
Blood flow velocities were measured in both MCA us ing TCD (TC 2-64B; Eden Medical Electronics Inc., Uberiingen, Germany). The instrument and the proce dure for artery identification have been described else where (Aaslid et aI., 1982) . Two flat monitoring probes were positioned and fixed with an elastic bandage in the temporal regions and adjusted until strong MCA signals were obtained. The monitoring probes were then kept in this position. Velocities were continuously measured throughout the study, alternating between the two sides every 15-20 s using a mechanical switching system placed between the Doppler instrument and the two probes. The velocity used was the time mean from the spectral outline (Aaslid et aI., 1982) . For comparison with rCBF, veloci ties measured during a 120-s period starting 20 s after the start of the 133Xe inhalation were used. End-expiratory Peoz, was measured continuously throughout the study using an infrared capnograph (Date x CD 102; Datex In strumentarium Corp., Helsinki, Finland).
rCBF and blood flow velocities were first measured simultaneously under basal conditions in all 36 subjects. One gram of acetazolamide was then given intravenously to 20 subjects and simultaneous measurements were re peated after 15-20 min, when the vasodilatory response is believed to be maximal. In 16 subjects, reproducibility was assessed by performing simultaneous measurements of rCBF and velocities on two occasions with a 20-min interval between the two studies.
Statistical evaluation
All values are given as means, with standard deviations in parentheses. All statistical tests were two-tailed and differences considered statistically significant if the p value was �0.05 (5%). Correlation analyses were carried out using the Pearson model and linear regression analy ses.
We also assessed to what extent lack of reproducibility could explain the poor correlation between rCBF and ve locity increases after acetazolamide administration. The reproducibility data were first assessed by a simple linear regression analysis, where the second measurement was the dependent (explanatory) variable. To fit one model for both sides of the body, one side (left or right) was included as a "dummy" variable (Kleinbaum et aI., 1988) . The side of the body was in fact important since the level differed significantly from left to right side. We therefore estimated the "measurement error" from this sample and used the sum of squares for further analysis. An additional regression analysis was then carried out in which the body sides (right and left) were classified as the explanatory variables. The covariates were the increases in rCBF or velocity following acetazolamide. The as sumption of a homogeneous slope was tested, and there was no indication of a significant interaction (p > 0.70). The usual assumption of normality of residuals and ho moscedasticity were checked using jackknife residuals and Cook's d. Mallow's Cp was used for assessing the validity of the model (Kleinbaum et aI., 1988) . The jack knife residuals were tested for normality using the Sha piro-Wilk statistic (Kleinbaum et aI., 1988) .
The influence of reproducibility was assessed by per forming repeated-measures analysis of variance as ex plained by Montgomery (1984) . This analysis partitions the total variation into several factors, the most important being the pure measurement error. It is important to try to evaluate the importance of dispersion due to measure ment alone. If this factor explains just a small part of the variability (i.e., clearly nonsignificant), then we can con clude that the reproducibility is acceptable. A large un explained variability in the reproducibility study suggests that there are other factors (not included or controlled for in this study) that are more important than the pure mea surement errors.
RESULTS

The Reproducibility Study
The results of the reproducibility study are shown in Tables 1 and 2. The correlation coefficient be tween the first and the second rCBF mea measure ment was calculated on both sides: Right side r = 0.86 (p < 0.001), and left side r = 0.8 5 (p < 0.001) .
Statistical analysis showed that reproducibility was within acceptable limits, as the variability due to measurement error was almost-zero. No positive relationship was found between changes in rCB.F and velocities observed from study 1 to study 2. Corrections for individual differences in Pco2 be tween the two studies did not improve the repro ducibility for velocity or rCBF. Figure 1 shows the individual differences between the first and the sec ond rCBF measurements in the right MCA perfu sion territory as proposed by Bland and Altman (1986) .
The change in asymmetry (right-left side) from the first to the second rCBF study was �3 ml 100 g-l min-1 in all subjects. This is illustrated in Fig.  2 . The SD was lower when calculating changes in asymmetry (SD = 1.7 ml 100 g -I min -I) compared to changes in absolute values (SD = 4.3 ml 100g-1 min -I) from the first to the second study.
A comparison of MCA flow velocities on each side measured during the first and the second study gave a correlation coefficient of 0.96 (p < 0.001) on both sides. The SD for changes in velocity asym metries from the first to the second study was less than the SD for changes in velocities on each side separately. This observation confirms relatively stable probe positions throughout the study.
The Acetazolamide Study reBF findings. Table 3 shows the rCBF in the MCA perfusion territory under basal conditions and after acetazolamide in 20 subjects. The change in asymmetry (right-left side) from basal conditions to 1.1 (2.2) 1.9 (3.9) -3-5.5 (-5.9-8.6) 2.1 (3.9) -1.5-4.5 (-2.7-7.9) Change in asymmetry (Oiff. study I -Oiff. study 2) that after acetazolamide injection was 4.5 ml 100 g-l min-1 in one subject but:;;;: : 3 ml 100 g-l min-1 in the remaining subjects. Basal flow values and the increase in flow after acetazolamide did not show a significant correlation: Right side r = 0. 19 (not sig nificant; NS), and left side r = 0.08 (NS).
TCD measurements. Table 4 shows MeA veloc ities before and after acetazolamide. The asymme try in MeA velocity values was considerable in some subjects when right and left sides were com pared. This is probably due to difficulties in obtain ing an optimal probe position with strong and stable ::
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The intercept of the regression lines was not differ ent from zero on either side.
Comparison of rCBF and TCD findings. Basal rCBF in the MCA perfusion territory showed a pos itive correlation with basal MCA velocities: Right side r = 0.74 (p < 0.001), and left side r = 0.69 (p < 0.005 ). The intercepts of the regression lines were not different from zero. rCBF and MCA velocities measured after acetazolamide also showed a posi tive correlation (right side r = 0.61, p < 0.01; left side r = 0.53, p < 0.02). The intercept of the re gression lines was not different from zero on either side. Asymmetry (right -left side) Before 0.6 (8.3)* -14-18
After -1.0 (8.9)* -19-12
In ACZ response -1.5 (7.7) -19-11
Change in asymmetry (diff. before ACZ -diff. after ACZ)
(%)
Mean Range -0.9 (4.0) -8-9
MCA velocity values (cm/s) with SD in parentheses. The per centage increase is the mean of the percentage increase in each subject. * Not statistically significant. Diff., difference. The increase in flow did not show a positive cor relation with the velocity increase. This was the case when both percentage and absolute values were compared for the two methods. When using percentage velocity increase and absolute rCBF in crease, the correlation coefficients were r = 0.19 (NS) on the right side: and r = 0.08 (NS) on the left side ( Fig. 4) .
Information about methodological inaccuracy ob tained from the reproducibility study was used in an attempt to explain this lack of relationship in a sit uation where the correlation coefficient theoretical ly should have been 1. Calculation of flow and ve locity increase is based on the difference between two measurements, both of which have a degree of inaccuracy. The statistical analysis of covariance, assessing the sum of squares, indicated that lack of reproducibility of these two measurements could explain only 0.25% of the total observed variation. Rt-MCA LirCBF (ml 100 g -1 min ') FIG. 4 . Increase in rCBF (ml 100 g-1 min-1) after acetazol amide (x axis) versus the percentage increase in blood flow velocity (V mea) (y axis). n = 19.
The unexplained variation made up 73 % of the total variation. This lack of agreement with the theoret ical model must therefore be due to other factors that were not taken into account in this trial. Fur thermore, Mallow's Cp suggests that further factors should be included (Kleinbaum et aI., 1988) .
DISCUSSION
We have assessed the intracranial vasodilatory response of 1 g of acetazolamide i. v. in healthy sub jects and found a simultaneous increase in MCA blood flow velocities and in rCBF in this artery's perfusion territory. The response was symmetrical and changes in side-to-side asymmetry with regard to velocity and rCBFmca were of the same magni tude as those observed in the reproducibility part of the study. These findings suggest that changes in side-to-side asymmetry are of more value than changes in absolute values on each side when as sessing vasoreactivity using acetazolamide. This observation of the highest reproducibility when as sessing asymmetry can be expected from method ological considerations (Lassen, 1985) . The range of flow and velocity increase was large, suggesting an individual response to acetazolamide, and the stan dard dose of 1 g of acetazolamide may be too low to give a near-maximal response in some subjects (Dahl and Russell, personal observations) . Higher doses, up to 22 mg/kg, have been used in other stud ies (Sullivan et aI., 1987) .
No relationship between the basal rCBF and the rCBF increase after acetazolamide was found. This is similar to findings in a previous study (Rootwelt et aI., 1986) . Our results support the suggestion that absolute rCBF values, and not the percentage in crease, should be used when defining normal limits for vasoreactivity using SPECT. The reason for this lack of relationship is difficult to explain, but differ ences in individual acetazolamide doses (mg/kg) when giving standard doses and some measurement inaccuracy may be at least partly responsible. Oth ers have found an inverse relationship between basal flow values and flow increase after acetazol amide administration (Leinsinger et al., 1988) .
Flow velocity measurements in absolute values (cm/s) showed a significant positive correlation be tween velocity increase and basal values. Assuming that the normal broad range of basal velocities is due to relatively large interindividual variations in MCA diameter (Gibo et aI., 1981) , and that the in crease in velocity reflects increase in volume flow, there should be a positive relationship between basal velocity and velocity increase in absolute val ues. In a narrow vessel with high basal velocities the increase in absolute velocities will be higher compared to that in a larger vessel with low basal velocities when the volume flow increase is similar. Our findings therefore support the use of percent age increase when assessing velocity increase after acetazolamide.
The present study did not show a positive rela tionship between the percentage increase in MCA velocity and the increase in rCBF in the MCA per fusion territory. Theoretically this relationship should have been good since an increase in volume flow should be proportional to the velocity increase when assuming no MCA diameter change or change in the magnitude of the MCA perfusion territory. We therefore discuss the lack of this relationship in more detail.
The velocity referred to in the formula in our in troductory section is the mean velocity in a cross section of the vessel. This "true" blood flow veloc ity is lower than the time mean of the maximal ve locities used in this study. Provided that flow is laminar in all of the subjects and that no substantial change in heart rate or pulsatility occurs after the injection of acetazolamide, there is probably a rel atively constant relationship between the time mean and the cross-sectional average velocity. Changes in the time mean of the maximal velocities should therefore reflect, to a large extent, changes in cross sectional average blood velocities. Studies in ani mals and humans support the use of the time-mean velocity as an index of changes in flow (Evans and Macpherson, 1982; Kirkham et aI., 1986; Linde gaard et al., 1987) .
The measured increase in rCBF and velocity caused by the acetazolamide injection is the differ ence between two rCBF and two TCD measure ments. The accuracy of each measurement has a large influence on the result when making compar isons. The reproducibility study indicated that the accuracy of combined rCBF and velocity measure ments is relatively good. The best way we have found to assess how much influence the lack of a perfect accuracy of the two methods has on the results is to perform a study of covariation. This statistical analysis suggested that other factors not taken into account in this study must be very im portant when attempting to explain the lack of a significant relationship.
The two assumptions given when assuming a strict relationship between flow and velocity in crease may therefore not be valid. Acetazolamide has a known vasodilatory effect on peripheral resis tance vessels. The effect on the large arteries near the circle of Willis is not known. One study has proposed a possible vasoconstriction (Sorteberg et aI., 1989b) . The percentage increase in rCBF is only slightly lower than the velocity increase, and if rCBF is not largely underestimated, this study does not indicate an overall change in diameter of the large intracranial vessels. However, a variable ef fect on vessel diameter cannot be completely ex cluded, and this would have a large effect on the comparison between flow and velocity. Further more, acetazolamide may have an variable effect on the magnitude of the MCA perfusion territory as suggested previously (Sorteberg et aI., 1989b) . Such a change could influence the comparison between the two methods when velocities are measured in only one major intracranial artery in each hemi sphere.
Our observation of a flow increase of about 29% is in agreement with others who have studied the effect of acetazolamide on healthy subjects using SPECT (Vorstrup et aI., 1986; Bonte et aI., 1988; Leinsinger et aI., 1988) . A greater increase in flow has been found using other CBF techniques (Chatz ipanagiotou et aI., 1989) . Vorstrup et aI. (1984) mea sured the increase in CBF after the injection of 1 g of acetazolamide using intraarterial xenon-13 3 in jection and calculated flow from the washout curve by three methods. CBF was also estimated from arteriovenous oxygen differences. The increase in flow was similar (57-75%) for all four methods in their six patients. The SPECT method may there fore underestimate the rCBF increase. The main reason is the partial volume effect, which is due to the fact that each pixel contains both white and gray matter. The average value for CBF in each pixel will therefore underestimate the flow in the gray matter. This underestimation is greatest with high flow values (Celsis et aI., 1981) . The calculation of flow from the clearance curve measured with sta tionary detectors will probablY not underestimate high flow values to the same degree, and thus the increase after acetazolamide will be calculated as being higher.
If the effect of acetazolamide on the diameter of the large vessels is negligible, our finding of a 34% velocity increase using TCD suggests that SPECT only slightly underestimates high flow. If, however, the true increase in flow is at the level calculated with stationary detectors, our findings of a 35% MCA velocity increase indicates that acetazolamide dilates the large intracranial vessels.
Comparison of SPECT and TCD assessments of vasoreactivity in patients with cerebrovascular dis ease has been carried out (Dahl et aI., 1992a (Dahl et aI., , 1994 . Some discrepancies were found between the two methods in some subjects when vasoreactivity val ues were just within or outside our normal limits.
J Cereb Blood Flow Metab, Vol. 14, No.6, 1994 However, it is stressed that the two methods a,greed in the assessment of an abnormal response in al most all subjects with marked findings. This sug gests that the TCD method may detect patients with a marked reduction in vasoreactivity. This is impor tant clinically since it is probably in these patients with marked findings that vasoreactivity results are of the greatest prognostic significance. However, the lack of a significant relationship found in the present study between the increase in MCA veloc ities and the rCBF suggests caution when trying to predict rCBF changes based on flow velocity after a vasodilatory stimulus.
The mean age of the subjects examined in this study is lower than that which is usually the case for patients with occlusive cerebrovascular disease. Studies assessing the relationship between cerebral vasoreactivity and age have shown conflicting re sults using rCBF measurements. H�yer-Pedersen (1987) found no change with age in the vasodilatory response to acetazolamide. Other authors have found an unchanged (Davis 1983) or reduced (Ya mamoto 1980) response when using hypercapnia. In our experience MCA velocity increases following acetazolamide seem to be similar in older and younger healthy subjects (Dahl and Russell, per sonal observations) . We therefore suggest that the findings in this study may also apply to older healthy subjects. However, age-matched control values should be used when assessing rCBF and velocity measurements in older patients.
In conclusion, our study supports the use of ac etazolamide to assess the reserve capacity of the collateral circulation of the brain. Particular atten tion should be paid to the symmetry of the response rather than to absolute values. The relationship found in this study between basal values and the increase in flow and velocity is of importance when decisions are being made as to how flow and veloc ity increase should be evaluated. The lack of a re lationship between the individual increase in rCBF and that in MCA flow velocity after acetazolamide supports previous suggestions that this drug may have other effects on intracranial hemodynamics besides an overall increase in flow and velocity.
